Keyword: Pradaxa

After testing local market TV last year, Boston Scientific has expanded its TV media run for its Watchman heart implant device.

It’s that time of year again—the time when lead PBM Express Scripts ignites pharma’s ire with a brand-new list of formulary exclusions.

The FDA has approved Portola Pharmaceuticals’ factor Xa inhibitor Bevyxxa, but now the company is facing plenty of challenges as it gets the drug off the ground.

Direct oral anticoagulants haven’t made the mark cardiology professionals had hoped in atrial fibrillation patients.

Pfizer and Bristol-Myers face three new lawsuits in New York claiming their big-selling anticoagulant Eliquis ended up hurting patients.

The award-winning computer-generated red fish of Pradaxa just keep swimming—this time through an aquarium in new TV work for Boehringer Ingelheim’s next-gen anticoagulant.

The first federal trial over the bleeding risks of Xarelto, Johnson & Johnson and Bayer’s blockbuster anticoagulant, kicks off next week.

The championship is here: Pradaxa’s "Red Fish" will take on Takeda’s "IBD Superheroes" in the final matchup of the DTC #FierceMadness tournament.

The fast and furious two-day Round 2 match-ups carved the pharma ad field down to 16, with disease awareness emerging as a winning theme.